EVENTS | VIEW CALENDAR
Biomagnetics to develop blood diagnostic device
SAN FRANCISCO—Biomagnetics Diagnostics Corp., a developer of diagnostic
systems and technology for HIV, hepatitis, tuberculosis and malaria detection,
announced in December that it has acquired intellectual property rights from
Los Alamos National Security for the development of an integrated optical
biosensor capable of screening blood donors for HIV/AIDS, hepatitis and tuberculosis.
The technology was originally developed at Los Alamos National Laboratory and
when utilized with the Integrated Optical Biosensor System (IBOS) licensed by
Biomagnetics from Los Alamos National Security, is capable of detecting
multiple pathogens from a single blood sample. Biomagnetics says it plans to
integrate these technologies into a handheld blood diagnostic device that can
be utilized by relatively unskilled personnel to screen potential blood donors
for various pathogens at the point of collection.